NCT04060290Completed
Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors
Source: ClinicalTrials.gov · Last updated 28 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a multi-center, Prospective, observational study，to evaluate the safety and influencing factors of albumin-bound paclitaxel in the real-world chinese population，and evaluate of the efficacy of albumin-bound paclitaxel in patients with malignant tumors and its impact on quality of life.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1000 (actual)
- First submitted
- 14 Aug 2019
- Start date
- 12 May 2020
- Primary completion date
- 1 Feb 2024
- Lead sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Diseases
- Childhood cancers
- NCT number
- NCT04060290
What you commit to
- Study type: Observational
- Participants enrolled: 1000
- From 12 May 2020 to the primary completion date, 1 Feb 2024
- 14 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No
Who the study is looking for
- In patients with malignant tumor who have been treated with albumin-bound paclitaxel for the treatment.
Sex: All · Does not accept healthy volunteers
Sites (14)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cancer Hospital, Chinese Academy of Medical Sciences Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Hainan General Hospital Coordinator of this site? Confirm its status | Haikou | China | Unknown status |
| The Second Affiliated Hospital Zhejiang University School of Medicine Coordinator of this site? Confirm its status | Hangzhou | China | Unknown status |
| Tumor Hospital of Harbin Medical University Coordinator of this site? Confirm its status | Harbin | China | Unknown status |
| Anhui Cancer Hospital Coordinator of this site? Confirm its status | Hefei | China | Unknown status |
| Inner Mongolia Autonomous Region Cancer Hospital Coordinator of this site? Confirm its status | Hohhot | China | Unknown status |
| Maanshan People's Hospital Coordinator of this site? Confirm its status | Maanshan | China | Unknown status |
| Zhongshan Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
| Liaoning Cancer Hospital Coordinator of this site? Confirm its status | Shenyang | China | Unknown status |
| The Fourth Hospital of Hebei Medical University Coordinator of this site? Confirm its status | Shijiazhuang | China | Unknown status |
| Shanxi Provincial Cancer Hospital Coordinator of this site? Confirm its status | Taiyuan | China | Unknown status |
| The Second Affiliated Hospital Of Xi'an Jiaotong University (Xibei Hospital) Coordinator of this site? Confirm its status | Xi'an | China | Unknown status |
| The First Affiliated Hospital of Xi'an Jiaotong University Coordinator of this site? Confirm its status | Xi’an | China | Unknown status |
| Henan Cancer Hospital Coordinator of this site? Confirm its status | Zhengzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.